Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03770702 |
Date of registration:
|
07/12/2018 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Statins and ARBs on Rheumatoid Activity
|
Scientific title:
|
Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients |
Date of first enrolment:
|
October 1, 2018 |
Target sample size:
|
45 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03770702 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
Phase 3
|
|
Countries of recruitment
|
Egypt
| | | | | | | |
Contacts
|
Name:
|
Sahar K Hegazy, Prof |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Head of Clinical Pharmacy Department |
|
Name:
|
Ahmed El-Abd, Msc |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
Ahmed HM El-Abd, Msc |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Clinical pharmacy Department-Tanta University |
|
Name:
|
Emad M Elshebini, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Rheumatology Dept. - Menoufia University |
|
Name:
|
Tarek M Mostafa, Prof |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Prof of Clinical Pharmacy |
|
Name:
|
Sherief Abd-Elsalam, Ph D |
Address:
|
|
Telephone:
|
00201147773440 |
Email:
|
sheriefabdelsalam@yahoo.com |
Affiliation:
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Rheumatoid arthritis.
Exclusion Criteria:
- Pregnant or lactating
- Hepatic or renal impairment.
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Rheumatoid Arthritis
|
Intervention(s)
|
Drug: Angiotensin receptor blockers
|
Drug: Statins
|
Primary Outcome(s)
|
Change in disease activity score
[Time Frame: 6 months]
|
Secondary ID(s)
|
Rheumatoid
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|